-
Mashup Score: 89
The benefit of percutaneous coronary intervention (PCI) in patients with stable coronary artery disease and severe aortic stenosis who are undergoing transcatheter aortic-valve implantation (TAVI) …
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2About eClinicalMedicine - 17 day(s) ago
About
Source: www.thelancet.comCategories: General Medicine News, General Journals & SocietTweet-
Attending #ESCCongress? Charlotte Rowbottom, Senior Editor, invites you to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: https://t.co/VIKkM0sChV https://t.co/BCIZ4a2w98
-
-
Mashup Score: 2About eClinicalMedicine - 20 day(s) ago
About
Source: www.thelancet.comCategories: General Medicine News, General Journals & SocietTweet-
Attending #ESCCongress? Charlotte Rowbottom, Senior Editor, invites you to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: https://t.co/VIKkM0sChV https://t.co/BCIZ4a2w98
-
-
Mashup Score: 8
Anthony A. Bavry, MD,MPH,FACC
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet-
ICYMI: M-TEER is noninferior to surgical mitral valve repair regarding clinical efficacy and has a better safety profile, according to results from the MATTERHORN trial presented at #ESCCongress in London. Read more: https://t.co/1eJh8WuW3w https://t.co/30H6QWCjYc
-
-
Mashup Score: 25Transcatheter Repair versus Mitral-Valve Surgery for Secondary Mitral Regurgitation | NEJM - 24 day(s) ago
Current treatment recommendations for patients with heart failure and secondary mitral regurgitation include transcatheter edge-to-edge repair and mitral-valve surgery. Data from randomized trials …
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
@escardio #ESCCongress @PCRonline @nejm https://t.co/nQzEmBsKCw MATTERHORN trial shows that in patients with heart failure and secondary mitral regurgitation, transcatheter edge-to-edge repair is non-inferior to surgery regarding clinical efficacy, and has a better safety… https://t.co/5942N6mROs https://t.co/YHEM0FlUDM
-
-
Mashup Score: 25Transcatheter Repair versus Mitral-Valve Surgery for Secondary Mitral Regurgitation | NEJM - 29 day(s) ago
Current treatment recommendations for patients with heart failure and secondary mitral regurgitation include transcatheter edge-to-edge repair and mitral-valve surgery. Data from randomized trials …
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
@escardio #ESCCongress @PCRonline @nejm https://t.co/nQzEmBsKCw MATTERHORN trial shows that in patients with heart failure and secondary mitral regurgitation, transcatheter edge-to-edge repair is non-inferior to surgery regarding clinical efficacy, and has a better safety… https://t.co/5942N6mROs https://t.co/YHEM0FlUDM
-
-
Mashup Score: 8Transcatheter Versus Surgical Mitral Valve Repair in Patients With Heart Failure and Secondary Mitral Regurgitation - American College of Cardiology - 1 month(s) ago
Anthony A. Bavry, MD,MPH,FACC
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet-
ICYMI: M-TEER is noninferior to surgical mitral valve repair regarding clinical efficacy and has a better safety profile, according to results from the MATTERHORN trial presented at #ESCCongress in London. Read more: https://t.co/1eJh8WuW3w https://t.co/30H6QWCjYc
-
-
Mashup Score: 14
Anthony A. Bavry, MD,MPH,FACC
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet-
ICYMI: The ABYSS trial failed to show that beta-blocker interruption is noninferior to continuation. ➡️ Access our Trial Summary from #ESCCongress here: https://t.co/CENIrPP2qj https://t.co/AuPsBYG4y8
-
-
Mashup Score: 15Highlights del Congreso Europeo de CardiologĂa 2024 - 2 month(s) ago
Highlights del Congreso Europeo de CardiologĂa 2024
Source: www.siacardio.comCategories: General Medicine News, CardiologistsTweet-
Quieres saber los puntos claves de las Ăşltimas guĂas Europeas presentadas en #ESCCongress La @SIAC_cardio te las trae Descárgalas aquà 👉🏻 https://t.co/0nnD218eXV https://t.co/jCHPbFi3zG
-
-
Mashup Score: 96Beta Blockers Post-MI? No for Me, Even After the ABYSS Trial - 2 month(s) ago
The need for routine beta blockers post MI in contemporary practice has been questioned but a randomized trial of stopping vs continuing suggested they still have a role. John Mandrola, MD, disagrees.
Source: www.medscape.comCategories: General Medicine News, Hem/OncsTweet-
It’s late in London but here’s my hot take of the ABYSS trial #ESCCongress — Okay to stop beta blockers after MI (good EF) https://t.co/hHdjzDHi70
-
@escardio #ESCCongress @PCRonline NOTION 3 Trial @nejm 🔗https://t.co/Qv9rj4jUbv International trial w 1:1 randomization Patients w severe symptomatic AS & at least one coronary-artery stenosis + FFR of 0.80 or less or a diameter stenosis of at least 90% either to undergo… https://t.co/IwUYUIECWu https://t.co/K0ljhSPUBk